Clarient launches new lung cancer test

News Outlet: 
Clarient Investor Relations
Date published: 
February 10, 2010
Download PDF: 
application/pdf iconclarient_pulmotype.pdf

Clarient Insight Dx Pulmotype is the first commercial test launched following the recent acquisition of HudsonAlpha resident associate Applied Genomics Inc.  AGI developed Pulmotype and recently validated the test with a clinical study cohort of more than 1,000 patients.  The peer-reviewed results were published in the August 2009 edition of Modern Pathology.  A link to that study can be accessed at www.clarientinc.com/pulmotype.

  • share